Editorial: Advances in Management and Treatment of High Myopia and Its Complications

Quan V Hoang; Xavier Chan; Xiangjia Zhu; Xiangtian Zhou; Xiangchao Shentu; Yi Lu

doi:10.3389/fmed.2022.846540

Editorial: Advances in Management and Treatment of High Myopia and Its Complications

Front Med (Lausanne). 2022 Mar 10:9:846540. doi: 10.3389/fmed.2022.846540. eCollection 2022.

Authors

Quan V Hoang^{1

2

3}, Xavier Chan¹, Xiangjia Zhu⁴, Xiangtian Zhou⁵, Xiangchao Shentu⁶, Yi Lu⁴

Affiliations

¹ Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS, Singapore, Singapore.
² Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
³ Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University College of Physicians and Surgeons, New York, NY, United States.
⁴ Eye Institute, Eye & ENT Hospital, Fudan University, Shanghai, China.
⁵ School of Optometry and Ophthalmology and Eye Hospital, Wenzhou Medical University, Wenzhou, China.
⁶ Department of Ophthalmology, The Second Affiliated Hospital of Zhejiang University, College of Medicine, Hangzhou, China.

No abstract available

Keywords: cataract surgery; high myopia (HM); highly myopic cataract (HMC); myopic choroidal neovascularization (mCNV); myopic macular degeneration; myopic traction maculopathy (MTM); pathologic myopia; refractive surgery.

Publication types

Editorial